(Rac)-NRL-1049 dihydrochloride

(Synonyms: (Rac)-BA-1049)

(Rac)-NRL-1049 is the racemic mixture of NRL-1049 (BA-1049 (free base)) (HY-162596). NRL-1049 is an orally available and selective ROCK2 inhibitor with IC50 values of 0.59 µM for ROCK2 and 26 µM for ROCK1, respectively. NRL-1049 modulates ROCK signaling, preserves blood-brain barrier integrity, reduces edema, seizures and hemorrhage, and alleviates cerebral cavernous malformation lesion burden. NRL-1049 can be used for the study of acute brain injury, ischemic stroke, and cerebral cavernous malformations.

For research use only. We do not sell to patients.

  • CAS No.: 863638-93-1
  • Formula: C16H23Cl2N3O2S
  • Molecular Weight:392.34
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All ROCK Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00